China Covid-19 Drug Delivery Devices Market Size & Outlook
China covid-19 drug delivery devices market, 2016-2027 (US$M)
Related Markets
China covid-19 drug delivery devices market highlights
- The China covid-19 drug delivery devices market generated a revenue of USD 113.3 million in 2021 and is expected to reach USD 102.7 million by 2027.
- The China market is expected to grow at a CAGR of -1.6% from 2022 to 2027.
- In terms of segment, prefilled syringe was the largest revenue generating product in 2021.
- Inhalers is the most lucrative product segment registering the fastest growth during the forecast period.
Covid-19 drug delivery devices market data book summary
| Market revenue in 2021 | USD 113.3 million |
| Market revenue in 2027 | USD 102.7 million |
| Growth rate | -1.6% (CAGR from 2021 to 2027) |
| Largest segment | Prefilled syringe |
| Fastest growing segment | Inhalers |
| Historical data | 2016 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2027 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Prefilled syringe, Inhalers |
| Key market players worldwide | AstraZeneca PLC ADR, Johnson & Johnson, Serum Institute of India Pvt. Ltd., GSK PLC ADR, Moderna Inc, Pfizer Inc, Bharat Biotech, PHARMAJET, Novavax Inc |
Other key industry trends
- In terms of revenue, China accounted for 4.5% of the global covid-19 drug delivery devices market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2027.
- In Asia Pacific, China covid-19 drug delivery devices market is projected to lead the regional market in terms of revenue in 2027.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 102.7 million by 2027.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
COVID-19 Drug Delivery Devices Market Scope
COVID-19 Drug Delivery Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China covid-19 drug delivery devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to covid-19 drug delivery devices market will help companies and investors design strategic landscapes.
Prefilled syringe was the largest segment with a revenue share of 67.52% in 2021. Horizon Databook has segmented the China covid-19 drug delivery devices market based on prefilled syringe, inhalers covering the revenue growth of each sub-segment from 2016 to 2027.
Reasons to subscribe to China covid-19 drug delivery devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China covid-19 drug delivery devices market databook
-
Our clientele includes a mix of covid-19 drug delivery devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China covid-19 drug delivery devices market, including forecasts for subscribers. This country databook contains high-level insights into China covid-19 drug delivery devices market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Partial client list
China covid 19 drug delivery devices market size, by product, 2016-2027 (US$M)
China COVID-19 Drug Delivery Devices Market Share, 2021 & 2027 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
